ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2309건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 55 | Unknown status | Umifenovir in Hospitalized COVID-19 Patients | COVID-19 | Drug: Umifenovir Drug: Interferon-β 1a Drug: Lopinavir / Ritonavir Drug: Single Dose of Hydroxychloroquine Drug: Standards of Care |
Phase 4 | Shahid Beheshti University of Medical Sciences | OTHER | 40 | All | 18 Years | Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of |
| 54 | Recruiting | UNAIR Inactivated COVID-19 Vaccine | Vaccine Reaction | Biological: UNAIR Inactivated COVID-19 Vaccine Biological: CoronaVac Biofarma COVID-19 Vaccine |
Phase 2 | Dr. Soetomo General Hospital, Indonesia-MoH, Universitas Airlangga, Biotis Pharmaceuticals, Indonesia | OTHER_GOV | 495 | All | 18 Years | Dr. Soetomo General Hospital, Surabaya, East Java, Indonesia |
| 53 | Recruiting | UNAIR Inactivated COVID-19 Vaccine Phase III (Immunobridging Study) | COVID-19 Vaccines | Biological: Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 μg Biological: CoronaVac Biofarma COVID-19 Vaccine |
Phase 3 | Dr. Soetomo General Hospital, Indonesia-MoH, Universitas Airlangga, Biotis Pharmaceuticals, Indonesia | OTHER_GOV | 4005 | All | 18 Years | Dr. Soebandi General Hospital, Jember, East Java, Indonesia Jember Paru Hospital, Jember, East Java, Indonesia Dr. Saiful Anwar General Hospital, Malang, East Java, Indonesia Airlangga University Hospital, Surabaya, East Java, Indonesia Dr. Soetomo General Hospital, Surabaya, East Java, Indonesia |
| 52 | Completed | University of Utah COVID-19 Hydrochloroquine Trial | Infectious Disease | Drug: Hydroxychloroquine Drug: Placebo oral tablet |
Phase 2 | University of Utah | OTHER | 368 | All | 18 Years | University of Utah, Salt Lake City, Utah, United States |
| 51 | Suspended | Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease | Covid19 | Drug: Part A: Upamostat 200 mg Drug: Part A: Upamostat 400 mg Drug: Part A and B: Placebo Drug: Part B: Upamostat 200 or 400 mg |
Phase 3 | RedHill Biopharma Limited | INDUSTRY | 310 | All | 18 Years | Beautiful Minds Clinical Research, Cutler Bay, Florida, United States Research in Miami Inc., Hialeah, Florida, United States South Florida Research Phase I-IV, Inc., Miami Springs, Florida, United States Angels Clinical Research Institute, Miami, Florida, United States Great Lakes Research Group, Bay City, Michigan, United States Henry Ford Hospital, emergency department, Detroit, Michigan, United States Prime Global Research, Bronx, New York, United States Montefiore Medical Center, Bronx, New York, United States On-Site Clinical Solutions, Charlotte, North Carolina, United States University Hospitals Cleveland, Cleveland, Ohio, United States Southwest Family Medicine Research, Dallas, Texas, United States Langeberg Medical Centre - Clinical Trials, Kraaifontein, Cape Town, South Africa Roodepoort Medicross Clinical Trial Research Centre, Roodepoort, Gauteng, South Africa FCRN Clinical Trial Centre, Vereeniging, Gauteng, South Africa PJ Sebastian, KwaZulu, Natal, South Africa Global Clinical Trials PTY (LTD), Arcadia, Pretoria, South Africa WorthWhile Clinical Trials, Benoni, South Africa |
| 50 | Terminated | UPMC OPTIMISE-C19 Trial, a COVID-19 Study | Covid19 | Biological: Lilly Bamlanivimab Biological: Regeneron Casirivimab + Imdevimab Biological: Lilly Bamlanivimab + Etesevimab Biological: Sotrovimab Biological: Bebtelovimab |
Phase 4 | Erin McCreary, University of Pittsburgh | OTHER | 4571 | All | 12 Years ~ 120 Years | UPMC, Pittsburgh, Pennsylvania, United States |
| 49 | Unknown status | Urine Alkalinisation in COVID-19 | Acute Kidney Injury | Drug: Sodium bicarbonate Drug: standard care |
Not Applicable | Guy's and St Thomas' NHS Foundation Trust, University of Pittsburgh | OTHER | 80 | All | 18 Years |
